Trouver une ressource
Consultez notre collection d’informations et de ressources organisées!
*Plus de ressources sont disponibles en anglais.
Sujet
Health Equity Toolkit
Outil
Recent research shows that practitioners who implement brief, practical strategies at the point of care can profoundly improve patients' experiences…
Source: EQUIP Health CareFormat: Lien
Publié : 2017
Sujets : Déterminants de la santé, Planifier l’équité, Substances spécifiques
The Case for Heroin-Assisted Treatment in Canada
Rapport
This report outlines the case for heroin-assisted treatment in Canada. Heroin-Assisted Treatment, or HAT, is a medical intervention that provides pre…
Source: Pivot Legal SocietyFormat: PDF
Publié : 2017
Sujets : Approches axées sur l’équité, Traitement et réduction des méfaits, Substances spécifiques
Scale up of Managed Alcohol Programs
Fiche d’information/infographie
In this bulletin, the authors provide some beginning guidance and suggestions for organizations looking to initiate or scale up a MAP. There is subst…
Source: Canadian Institute for Substance Use Research (CISUR)Format: PDF
Publié : 2020
Sujets : Réduction des méfaits, Programme de gestion de l’alcoolisme, Substances spécifiques
Cannabis (Canadian Drug Summary)
Rapport
This report provides an overview of key data and information about cannabis before and after legalization and regulation, as well as on new classes o…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2020
Sujets : Surveillance nationale, Substances spécifiques
Prescription Opioids (Canadian Drug Summary)
Rapport
This report summarizes data on the use of prescription opioids, including information on associated harms and effects, legal status, costs, hospitali…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2020
Sujets : Surveillance nationale, Substances spécifiques
Sedatives (Canadian Drug Summary)
Rapport
This report summarizes data on the prescription and non-medical use of sedatives, including information on the effects, associated harms, and availab…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2019
Sujets : Surveillance nationale, Substances spécifiques
Sédatifs (Sommaire canadien sur la drogue)
Rapport
Résume les données sur la prescription et l’usage non médical de sédatifs, notamment sur les effets, les méfaits connexes et la disponibilité. Depuis…
Source: Centre canadien sur les dépendances et l'usage de substancesFormat: PDF
Publié : 2019
Sujets : Surveillance nationale, Substances spécifiques
Prescription Stimulants (Canadian Drug Summary)
Rapport
This report summarizes data on the use and misuse of prescription stimulants, including the harms and effects, legal status, and access to treatment…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2019
Sujets : Surveillance nationale, Substances spécifiques
Ecstasy or Molly (MDMA) (Canadian Drug Summary)
Rapport
This report summarizes research on the use of MDMA (street named ecstasy or molly), a synthetically derived chemical used recreationally. Less than 1…
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2017
Sujets : Surveillance nationale, Substances spécifiques
Clearing the Smoke on Cannabis: Medical Use of Cannabis and Cannabinoids - An Update
Rapport
Reviews research on the effects of cannabis use on various aspects of human functioning and examines the research on the medical use of cannabis and …
Source: Canadian Centre on Substance Use and Addiction (CCSA)Format: PDF
Publié : 2016
Sujets : Approches stratégiques et de légalisation, Raisons incitant les personnes à consommer des substances, Substances spécifiques